Clinical Trials

Cancer clinical trials help answer important questions about medical care in an effort to develop new and improved ways to treat all patients with cancer and those who will develop cancer in the future.

See current clinical trials available at the Duke Cancer Institute.

Research Overview

The Duke Cancer Institute’s multidisciplinary team of physician-scientists and associated health specialists forms a network of expertise that speeds laboratory discoveries into more effective ways to treat and prevent cancer.

We have been involved in several unique discoveries that have broadened our understanding of how these diseases arise and how to prevent them. For example:

• Duke scientists were members of the team that discovered the BRCA1 and BRCA2 genes, mutations in which are a leading cause of inherited breast and ovarian cancers.
• Duke is a member of The National Cancer Institute’s Cancer Genetics Network (CGN).
• Researchers at the eight sites in the CGN have created a registry of individuals at increased risk for cancer and are looking at clinical implications of inherited cancer syndromes.